CS-3150
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Primary Aldosteronism
Conditions
Primary Aldosteronism
Trial Timeline
Sep 1, 2016 → Jul 20, 2017
NCT ID
NCT02885662About CS-3150
CS-3150 is a pre-clinical stage product being developed by Daiichi Sankyo for Primary Aldosteronism. The current trial status is completed. This product is registered under clinical trial identifier NCT02885662. Target conditions include Primary Aldosteronism.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02885662 | Pre-clinical | Completed |
| NCT02807974 | Phase 3 | Completed |
| NCT02808026 | Phase 3 | Completed |
| NCT02807987 | Phase 3 | Completed |
| NCT02722265 | Phase 3 | Completed |
| NCT02448628 | Phase 2 | Completed |
Competing Products
20 competing products in Primary Aldosteronism